Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis

Brain

Volumn 132, Issue 12, 2009, Pages 3392-3400

  Yeh, E A ^a,b   Weinstock Guttman, B ^a,b   Ramanathan, M ^a,b   Ramasamy, D P ^a   Willis, L ^a   Cox, J L ^a   Zivadinov, R ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Magnetic resonance imaging; Multiple sclerosis; Paediatric; Paediatric onset multiple sclerosis, adult onset multiple sclerosis

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; ARTICLE; BRAIN ATROPHY; CHILD; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REGRESSION ANALYSIS; SCHOOL CHILD; TISSUE SPECIFICITY; WHITE MATTER;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ATROPHY; BRAIN; BRAIN MAPPING; CHILD; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 72649083519     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp278     Document Type: Article

References (34)

1. Amato MP, Goretti B, Ghezzi A, Lori S, Zipoli V, Portaccio E, et al. Cognitive and psychosocial features of childhood and juvenile multiple sclerosis. Neurology 2008; 70: 1891-1897
2. Anderson V, Spencer-Smith M, Leventer R, Coleman L, Anderson P, Williams J, et al. Childhood brain insult: can age at insult help us predict outcome? Brain 2009; 132: 45-56.
3. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage 2000; 11: 805-821
4. Banwell B, Shroff M, Ness JM, Jeffery D, Schwid S, Weinstock-Guttman B. MRI features of paediatric multiple sclerosis. Neurology 2007; 68: S46-53.
5. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 1999; 5: 283-286
6. Benedict RH, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, Weinstock-Guttman B, et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006; 63: 1301-1306
7. Callen DJ, Shroff MM, Branson HM, Lotze T, Li DK, Stephens D, et al. MRI in the diagnosis of paediatric multiple sclerosis. Neurology 2009; 72: 961-967
8. Chabas D, Strober J, Waubant E. Paediatric multiple sclerosis. Curr Neurol Neurosci Rep 2008; 8: 434-441
9. Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 2342-2352
10. Filippi M, Rossi P, Campi A, Colombo B, Pereira C, Comi G. Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability. AJNR Am J Neuroradiol 1997; 18: 1549-1556 (Pubitemid 30413972)
11. Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, et al. Grey matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64: 247-254
12. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 1999; 2: 861-863
13. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in paediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009; 66: 54-59
14. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for paediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7-12.
15. Lai M, Hodgson T, Gawne-Cain M, Webb S, MacManus D, McDonald WI, et al. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 339-341
16. MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005; 64: 1422-1425
17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127
18. Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, et al. Evidence of thalamic grey matter loss in paediatric multiple sclerosis. Neurology 2008; 70: 1107-1112
19. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846
20. Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007; 356: 2603-2613
21. Rocca MA, Absinta M, Valsasina P, Ciccarelli O, Marino S, Rovira A, et al. Abnormal connectivity of the sensorimotor network in patients with multiple sclerosis: a multicenter fMRI study. Hum Brain Mapp 2009; 30: 2412-2425
22. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-1151
23. Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, et al. Course and prognosis in early-onset multiple sclerosis: comparison with adult-onset forms. Neurology 2002; 59: 1922-1928
24. Sowell ER, Trauner DA, Gamst A, Jernigan TL. Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. Dev Med Child Neurol 2002; 44: 4-16.
25. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990; 300: 631-634
26. Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, et al. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 2005; 64: 1001-1007
27. Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, et al. Difference in disease burden and activity in paediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol 2009; 66: 967-971
28. Zivadinov R. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology 2007; 68: S72-82; discussion S91-6.
29. Zivadinov R. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials. Methods Find Exp Clin Pharmacol 2009; 31: 29-40.
30. Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J Neuroimaging 2004; 14: S27-35.
31. Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting multiple sclerosis. Neurology 2001; 57: 1239-1247
32. Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis I: inflammation and lesions. Front Biosci 2004; 9: 665-683 (Pubitemid 39043742)
33. Zivadinov R, Weinstock-Guttman B, Benedict R, Tamano-Blanco M, Hussein S, Abdelrahman N, et al. Preservation of grey matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet 2007; 16: 2659-2668
34. Zivadinov R, Weinstock-Guttman B, Hashmi K, Abdelrahman N, Stosic M, Dwyer MG, et al. Smoking is associated with increased LVs and brain atrophy in multiple sclerosis. Neurology 2009; 73: 504-510